Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Fox Chase Cancer Center
AC Camargo Cancer Center
Hoffmann-La Roche
Emory University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Adherex Technologies, Inc.